PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-0.21%
Negative revenue growth while FSLR stands at 41.85%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-11.62%
Negative gross profit growth while FSLR is at 194.48%. Joel Greenblatt would examine cost competitiveness or demand decline.
-170.82%
Negative EBIT growth while FSLR is at 596.31%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-34.04%
Negative operating income growth while FSLR is at 596.31%. Joel Greenblatt would press for urgent turnaround measures.
-965.36%
Negative net income growth while FSLR stands at 266.39%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-920.00%
Negative EPS growth while FSLR is at 264.89%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-1125.00%
Negative diluted EPS growth while FSLR is at 263.44%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
1.56%
Share count expansion well above FSLR's 0.05%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
-13.07%
Reduced diluted shares while FSLR is at 0.68%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
50.99%
OCF growth under 50% of FSLR's 222.80%. Michael Burry might suspect questionable revenue recognition or rising costs.
33.16%
FCF growth 50-75% of FSLR's 56.76%. Martin Whitman would see if structural disadvantages exist in generating free cash.
253.43%
10Y revenue/share CAGR under 50% of FSLR's 5211.81%. Michael Burry would suspect a lasting competitive disadvantage.
-51.51%
Negative 5Y CAGR while FSLR stands at 34.32%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-48.93%
Negative 3Y CAGR while FSLR stands at 30.60%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-227.20%
Negative 10Y OCF/share CAGR while FSLR stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-152.69%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-185.48%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-603.56%
Negative 10Y net income/share CAGR while FSLR is at 66944.94%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-296.64%
Negative 5Y net income/share CAGR while FSLR is 65.03%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-1.15%
Negative 3Y CAGR while FSLR is 239.49%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
254.46%
Equity/share CAGR of 254.46% while FSLR is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
-24.80%
Negative 5Y equity/share growth while FSLR is at 38.43%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
19.02%
3Y equity/share CAGR at 50-75% of FSLR's 35.14%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-31.50%
Firm’s AR is declining while FSLR shows 64.19%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
12.62%
We show growth while FSLR is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
1.05%
Asset growth well under 50% of FSLR's 3.77%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
-2.39%
We have a declining book value while FSLR shows 7.47%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
4.50%
We have some new debt while FSLR reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
21.46%
R&D growth drastically higher vs. FSLR's 0.51%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-0.50%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.